A U.S.-based biotech company has unveiled a new IVF option that allows parents to select embryos based on genetic markers tied to health and longevity. DNA testing and analysis company Nucleus Genomics has announced the world's first genetic optimization software that 'helps parents pursuing IVF see and understand the complete genetic profile of each of their embryos.'
